What is the central question of this study? Is there an interaction between histamine and the GABAergic system in modulation of anxiety in mice? What is the main finding and its importance? There is a synergistic anxiogenic effect between histamine and bicuculline in mice. This effect may be due to a direct or an indirect effect of the histaminergic system on the GABAergic system. It has been documented that both histaminergic and GABAergic systems participate in the neurobiology of anxiety behaviour. In the current research, we investigated the effects of the histaminergic system and GABAA receptor agents on anxiety-related behaviours and their interaction using the elevated plus maze test in mice. Intraperitoneal (i.p.) administration of muscimol (0.12 and 0.25mg/kg) increased the open arm time (OAT) (P<0.001) without affecting the open arm entries (OAE) and locomotor activity, showing an anxiolytic effect. i.p. injection of bicuculline (0.5 and 1mg/kg) decreased OAT (P<0.001) but not OAE and locomotor activity, suggesting an anxiogenic behaviour. Intracerebroventricular (i.c.v.) microinjection of histamine (2.5 and 5μg/mouse) resulted in a decline in OAT (P<0.001) but not OAE and locomotor activity, indicating an anxiogenic response. Co-administration of histamine with GABAergic agents, muscimol (0.06mg/kg; i.p.) and bicuculline (0.25mg/kg; i.p.), decreased (P<0.001) and increased (P<0.05), respectively, the anxiogenic-like response to the effective dose (5μg/mouse; i.c.v.) of histamine. In addition, co-treatment of effective doses of histamine (2.5 and 5μg/mouse;i.c.v.) with an effective dose of muscimol (0.12mg/kg; i.p.) and a non-effective dose of bicuculline (0.25mg/kg; i.p.) significantly decreased OAT (P<0.001), suggesting a likely interaction between the histaminergic and GABAergic systems in the regulation of anxiety. The results demonstrated a synergistic anxiogenic-like effect between histamine and bicuculline in mice. In conclusion, our results present an interaction between the histaminergic and GABAergic systems in anxiolytic/anxiogenic-like behaviours in the elevated plus maze test.